Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2022-03-31 2022-12-20 157650
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2022-04-28 2023-01-19 159584
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2022-06-16 2023-04-28 162846
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2020-11-06 2021-03-18 128031
AMPICILLIN SODIUM FOR INJECTION, USP 1000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86939
AMPICILLIN SODIUM FOR INJECTION, USP 2000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86942
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2019-06-27 2019-11-07 87653
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-05-27 2021-08-06 140036
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-06-03 2021-08-05 140369
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2019-09-05 2019-09-19 93110
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Actual shortage 2025-04-04 2025-04-24 254136
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2021-07-08 2021-08-24 142189
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2021-08-13 2021-10-07 144105
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2021-10-28 2021-11-25 148421
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2022-01-27 2022-12-20 153739
APRI 21 0.03MG 0.15MG TABLET Resolved 2022-10-28 2022-12-02 173067
APRI 21 0.15MG 0.03MG TABLET Resolved 2017-05-23 2017-09-19 10868
APRI 28 0.15MG 0.03MG TABLET Resolved 2017-05-23 2017-09-19 10871
APRI 28 0.03MG 0.15MG TABLET Resolved 2022-10-28 2022-12-02 173064
APRI 28 0.15MG 0.03MG TABLET Resolved 2019-08-29 2019-10-24 92660

Showing 301 to 320 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-03-20 2025-03-20 253165
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2024-10-11 2024-10-11 240081
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2021-02-12 2021-02-12 133908
TEVA-NAPROXEN 250MG TABLET Discontinued 2017-06-27 2017-06-27 14055
TEVA-NAPROXEN SODIUM DS 550MG TABLET Discontinued 2019-04-11 2019-04-11 81350
TEVA-NORFLOXACIN 400MG TABLET Discontinued 2018-10-19 2018-10-19 65013
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63946
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63949
TEVA-NYSTATIN 100000UNIT CREAM Discontinued 2020-07-10 2020-07-10 120056
TEVA-OXYBUTYNIN 5MG TABLET Discontinued 2024-06-28 2024-06-29 231586
TEVA-OXYBUTYNIN 5MG TABLET Discontinued 2024-10-11 2024-10-11 240078
TEVA-PANTOPRAZOLE MAGNESIUM 40MG TABLET (DELAYED-RELEASE) Discontinued 2021-02-12 2021-02-12 133891
TEVA-PAROXETINE 10MG TABLET Discontinued 2025-03-20 2025-03-20 253182
TEVA-PAROXETINE 10MG TABLET Discontinued 2019-04-11 2019-04-11 81313
TEVA-PAROXETINE 20MG TABLET Discontinued 2025-03-20 2025-03-20 253160
TEVA-PAROXETINE 30MG TABLET Discontinued 2019-12-09 2019-12-09 100540
TEVA-PAROXETINE 20MG TABLET Discontinued 2019-12-09 2019-12-09 100547
TEVA-PAROXETINE 10MG TABLET Discontinued 2020-02-21 2020-02-21 106898
TEVA-PAROXETINE 30MG TABLET Discontinued 2020-02-21 2020-02-21 106901
TEVA-PIOGLITAZONE 45MG TABLET Discontinued 2018-10-19 2018-10-19 65033

Showing 221 to 240 of 299